Advertisement

Pharmaceutisch weekblad

, Volume 3, Issue 1, pp 653–655 | Cite as

Ongeregistreerde geneesmiddelen in perspectief

  • J. R. B. J. Brouwers
Commentaar
  • 13 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatuur

  1. Culbert, M.L. (1974) In:The fight for Laetrile, forbidden weapon against cancer. Arlinghton House Publ., New York.Google Scholar
  2. Hill, H.Z., R. Backer enG.J. Hill (1980)Biopharm. & Drug Disp. 1, 211–220.CrossRefGoogle Scholar
  3. Horrobin, D.F. (1979) In: Brochure Hoffman-La Roche, 20 februari 1981.Google Scholar
  4. Fülgraff, G. (1980)Trends in Pharm. Sci. 1, 19, 1–11.Google Scholar
  5. Leading Article (1980)Brit. Med. J. I, 1484–1485.Google Scholar
  6. Smith, T. (1980a)Brit. Med. J. II, 1255–1257;Ibidem (1980b), 1333–1335.CrossRefGoogle Scholar
  7. Wardell, W.M., enD. Phil (1973)Clin. Pharmacol. Therap. 14, 1022–1034;Ibidem (1974)15, 73–96.CrossRefGoogle Scholar

Copyright information

© Bohn, Scheltema & Holkema 1981

Authors and Affiliations

  • J. R. B. J. Brouwers

There are no affiliations available

Personalised recommendations